As the operating landscape for pharmaceutical R&D becomes more cost-constrained, critical decision-making and a clear corporate strategy are evidently crucial elements in Strategic Project and Portfolio Management (PPM). PPM innovation will allow streamlined processes to actively support resource allocation, investment and commercial translation for market success. This marcus evans conference will look at how to transform your promising drug candidates into successful revenue producing projects and portfolios that align to your corporate business goals. As evolving portfolios require increasingly more investment and management, this conference certainly covers your daily “what ifs”, “how”, “when” and “why” for PPM.
Emulating on our previous successful annuals, this year we will focus on early decision making tactics to conquer the preclinical uncertainties that delay your project and portfolio expansion. The potential value, clinical promise, market need and competitor space are all factors that need to be considered to help make these early decisions. Come and learn how to turn these into your PPM parameters and indications! As more strategic collaborations are made, this conference will also inform delegates on how to manage their partnerships with peers to gain maximum benefit whilst minimising cost and risk. To benefit from the best PPM practices, register your interest today and secure your commercial success!